These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18092121)

  • 1. CORONA study highlights challenges of treating older patients with systolic heart failure.
    Cardiovasc J Afr; 2007; 18(6):402-4. PubMed ID: 18092121
    [No Abstract]   [Full Text] [Related]  

  • 2. Statins for ischemic systolic heart failure.
    Masoudi FA
    N Engl J Med; 2007 Nov; 357(22):2301-4. PubMed ID: 17984167
    [No Abstract]   [Full Text] [Related]  

  • 3. CORONA--rosuvastatin in older patients with systolic heart failure.
    Jackson G
    Int J Clin Pract; 2008 Jan; 62(1):1. PubMed ID: 18173807
    [No Abstract]   [Full Text] [Related]  

  • 4. Rosuvastatin in older patients with systolic heart failure.
    Florkowski CM; Molyneux SL; George PM
    N Engl J Med; 2008 Mar; 358(12):1301; author reply 1301. PubMed ID: 18354111
    [No Abstract]   [Full Text] [Related]  

  • 5. CORONA, statins, and heart failure: who lost the crown?
    Athyros VG; Kakafika AI; Tziomalos K; Karagiannis A; Mikhailidis DP
    Angiology; 2008; 59(1):5-8. PubMed ID: 18319216
    [No Abstract]   [Full Text] [Related]  

  • 6. Beyond coronary artery disease: rosuvastatin in older patients with ischemic systolic heart failure.
    Capurso C; Solfrizzi V; D'Introno A; Colacicco AM; Gadaleta A; Frisardi V; Santamato A; Capurso A; Panza F
    J Am Geriatr Soc; 2008 Jul; 56(7):1366-7. PubMed ID: 18774975
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled Rosuvastatin Multinational Trial In Heart Failure (the positive negative trial).
    Serebruany VL
    Am J Cardiol; 2008 Jun; 101(12):1808-9. PubMed ID: 18549865
    [No Abstract]   [Full Text] [Related]  

  • 8. [The CORONA study].
    Metra M; Zacá V; Nodari S; Cas LD; Maggioni AP
    G Ital Cardiol (Rome); 2008 Apr; 9(4):229-33. PubMed ID: 18543792
    [No Abstract]   [Full Text] [Related]  

  • 9. Can natriuretic peptides help identify heart failure patients for whom statins are beneficial?
    Daniels LB; Barrett-Connor E
    J Am Coll Cardiol; 2009 Nov; 54(20):1860-1. PubMed ID: 19892236
    [No Abstract]   [Full Text] [Related]  

  • 10. Coenzyme Q10, rosuvastatin, and clinical outcomes in heart failure: a pre-specified substudy of CORONA (controlled rosuvastatin multinational study in heart failure).
    McMurray JJ; Dunselman P; Wedel H; Cleland JG; Lindberg M; Hjalmarson A; Kjekshus J; Waagstein F; Apetrei E; Barrios V; Böhm M; Kamenský G; Komajda M; Mareev V; Wikstrand J;
    J Am Coll Cardiol; 2010 Oct; 56(15):1196-204. PubMed ID: 20883926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The GISSI-HF trial].
    Tavazzi L; Nodari S
    G Ital Cardiol (Rome); 2009 Mar; 10(3):129-34. PubMed ID: 19385306
    [No Abstract]   [Full Text] [Related]  

  • 12. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
    Krum H; Ashton E; Reid C; Kalff V; Rogers J; Amarena J; Singh B; Tonkin A
    J Card Fail; 2007 Feb; 13(1):1-7. PubMed ID: 17338996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [No reason to start treatment with statins in patients with moderate to severe heart failure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):486-8. PubMed ID: 18389878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low coenzyme Q₁₀ levels and the outcome of statin treatment in heart failure.
    Mortensen SA
    J Am Coll Cardiol; 2011 Apr; 57(14):1569; author reply 1569. PubMed ID: 21453843
    [No Abstract]   [Full Text] [Related]  

  • 15. Rosuvastatin and cardiovascular continuum when time is important.
    Barrios V; Escobar C
    J Am Coll Cardiol; 2010 Apr; 55(15):1645-6; author reply 1646. PubMed ID: 20378088
    [No Abstract]   [Full Text] [Related]  

  • 16. Rationale and design of the GISSI heart failure trial: a large trial to assess the effects of n-3 polyunsaturated fatty acids and rosuvastatin in symptomatic congestive heart failure.
    Tavazzi L; Tognoni G; Franzosi MG; Latini R; Maggioni AP; Marchioli R; Nicolosi GL; Porcu M;
    Eur J Heart Fail; 2004 Aug; 6(5):635-41. PubMed ID: 15302013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleiotropic effects of long-term monotherapy with rosuvastatin in dogs with moderate heart failure.
    Chello M; Spadaccio C
    Cardiology; 2013; 124(1):36-7. PubMed ID: 23295545
    [No Abstract]   [Full Text] [Related]  

  • 18. N-3 polyunsaturated fatty acids and statins in heart failure.
    Solfrizzi V; Capurso C; Vendemiale G; Capurso A; Panza F
    Lancet; 2009 Jan; 373(9661):380; author reply 380-1. PubMed ID: 19186269
    [No Abstract]   [Full Text] [Related]  

  • 19. Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials.
    Takagi H; Umemoto T
    Int J Cardiol; 2012 Mar; 155(2):296-9. PubMed ID: 22200185
    [No Abstract]   [Full Text] [Related]  

  • 20. [Statin therapy for systolic heart failure. The CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure)].
    Angermann CE; Nitschmann S
    Internist (Berl); 2008 Jul; 49(7):884-6. PubMed ID: 18427760
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.